跳转至内容
Merck
CN
  • Hypoxia‑inducible adrenomedullin ameliorates the epithelial-to-mesenchymal transition in human proximal tubular epithelial cells.

Hypoxia‑inducible adrenomedullin ameliorates the epithelial-to-mesenchymal transition in human proximal tubular epithelial cells.

Molecular medicine reports (2015-01-15)
Tiechui Zhu, Jun Yang, Xiangdong Liu, Lianyun Zhang, Jie Zhang, Yongtao Wang, Haijun Ma, Zhenhui Ren
摘要

Renal tubular epithelial cells can enter the epithelial‑to‑mesenchymal transition (EMT) in response to chronic hypoxia. EMT is a process which involves the phenotypic conversion of epithelial cells, that is believed to have an important role in renal fibrosis. However, the underlying mechanisms of the involvement of EMT in renal fibrosis remain to be elucidated. Adrenomedullin (AMD) has been implicated in renal fibrosis and is induced by hypoxia. The aims of the present study were to determine whether ADM signaling was active in human proximal tubular epithelial cells cultured under hypoxic conditions, and to observe the activity of ADM during EMT. The expression levels of ADM were significantly increased, in a time‑dependent manner, in HK‑2 and HKC human proximal tubular epithelial cells, cultured under hypoxic conditions. Overexpression of exogenous ADM was accompanied by increased expression levels of the epithelial markers E‑cadherin and tight junction protein‑1, and decreased expression levels of the mesenchymal markers vimentin and α‑smooth muscle actin, during hypoxia. Knock‑down of ADM expression by small hairpin RNA, or co‑administration of an ADM peptide inhibitor, in HK‑2 cells significantly exacerbated hypoxia‑induced EMT, as compared to the lack of effect observed in the untransfected controls. ADM was shown to suppress EMT by inhibiting the activation of extracellular signal‑regulated kinase (ERK), and this effect was prevented by the ERK activator apigenin. The results of the present study suggest that ADM has an important role in promoting EMT in hypoxic human proximal tubular epithelial cells. ADM may therefore represent a novel therapeutic target in the treatment of injured kidneys.

材料
货号
品牌
产品描述

Sigma-Aldrich
硒, powder, −100 mesh, 99.99% trace metals basis
Sigma-Aldrich
硒, powder, −100 mesh, ≥99.5% trace metals basis
Sigma-Aldrich
芹菜素, ≥95.0% (HPLC)
Sigma-Aldrich
硒, pellets, <5 mm particle size, ≥99.999% trace metals basis
Sigma-Aldrich
硒, pellets, <5 mm, ≥99.99% trace metals basis
Sigma-Aldrich
三(叔丁氧基)硅烷醇, 99.999%
Sigma-Aldrich
氢化可的松, meets USP testing specifications
硒, foil, 25x25mm, thickness 3mm, 99.95%
Sigma-Aldrich
MISSION® esiRNA, targeting human ADM